Versant Capital Management’s CARGO Therapeutics CRGX Stock Holding History

Versant Capital Management’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-63	Closed	-$260	–	2656
2025 Q2	$260	Sell	63 -2,139	-97%	-$9.16K	﹤0.01%	2585
2025 Q1	$8.96K	Buy	+2,202	New	+$14.7K	﹤0.01%	1778

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Versant Capital Management's CRGX Position: Q3 2025 in Review

Versant Capital Management sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 63 shares — an estimated $260 sold.

Versant Capital Management first reported a position in CRGX in Q1 2025 and held it in 2 quarters. The position peaked at $8.96K in Q1 2025. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Versant Capital Management reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Versant Capital Management sold 63 CARGO Therapeutics shares in Q3 2025, an estimated $260.
Versant Capital Management first reported a position in CARGO Therapeutics in Q1 2025 and held it in 2 quarters.
Versant Capital Management's CARGO Therapeutics position peaked at $8.96K in Q1 2025.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Versant Capital Management's 13F filing for Q3 2025, filed 27 Oct 2025.